120 related articles for article (PubMed ID: 18974116)
1. Deleted in liver cancer 1 controls cell migration through a Dia1-dependent signaling pathway.
Holeiter G; Heering J; Erlmann P; Schmid S; Jähne R; Olayioye MA
Cancer Res; 2008 Nov; 68(21):8743-51. PubMed ID: 18974116
[TBL] [Abstract][Full Text] [Related]
2. Akt phosphorylation of deleted in liver cancer 1 abrogates its suppression of liver cancer tumorigenesis and metastasis.
Ko FC; Chan LK; Tung EK; Lowe SW; Ng IO; Yam JW
Gastroenterology; 2010 Oct; 139(4):1397-407. PubMed ID: 20600027
[TBL] [Abstract][Full Text] [Related]
3. Rho GTPase-activating protein deleted in liver cancer suppresses cell proliferation and invasion in hepatocellular carcinoma.
Wong CM; Yam JW; Ching YP; Yau TO; Leung TH; Jin DY; Ng IO
Cancer Res; 2005 Oct; 65(19):8861-8. PubMed ID: 16204057
[TBL] [Abstract][Full Text] [Related]
4. The SAM domain of the RhoGAP DLC1 binds EF1A1 to regulate cell migration.
Zhong D; Zhang J; Yang S; Soh UJ; Buschdorf JP; Zhou YT; Yang D; Low BC
J Cell Sci; 2009 Feb; 122(Pt 3):414-24. PubMed ID: 19158340
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous loss of the DLC1 and PTEN tumor suppressors enhances breast cancer cell migration.
Heering J; Erlmann P; Olayioye MA
Exp Cell Res; 2009 Sep; 315(15):2505-14. PubMed ID: 19482022
[TBL] [Abstract][Full Text] [Related]
6. Focal adhesion-localization of START-GAP1/DLC1 is essential for cell motility and morphology.
Kawai K; Iwamae Y; Yamaga M; Kiyota M; Ishii H; Hirata H; Homma Y; Yagisawa H
Genes Cells; 2009 Feb; 14(2):227-41. PubMed ID: 19170769
[TBL] [Abstract][Full Text] [Related]
7. DLC1 is the principal biologically-relevant down-regulated DLC family member in several cancers.
Wang D; Qian X; Rajaram M; Durkin ME; Lowy DR
Oncotarget; 2016 Jul; 7(29):45144-45157. PubMed ID: 27174913
[TBL] [Abstract][Full Text] [Related]
8. Deleted in liver cancer 2 suppresses cell growth via the regulation of the Raf-1-ERK1/2-p70S6K signalling pathway.
Leung TH; Yam JW; Chan LK; Ching YP; Ng IO
Liver Int; 2010 Oct; 30(9):1315-23. PubMed ID: 20629949
[TBL] [Abstract][Full Text] [Related]
9. The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formation.
Seng TJ; Low JS; Li H; Cui Y; Goh HK; Wong ML; Srivastava G; Sidransky D; Califano J; Steenbergen RD; Rha SY; Tan J; Hsieh WS; Ambinder RF; Lin X; Chan AT; Tao Q
Oncogene; 2007 Feb; 26(6):934-44. PubMed ID: 16862168
[TBL] [Abstract][Full Text] [Related]
10. DLC1 interacts with 14-3-3 proteins to inhibit RhoGAP activity and block nucleocytoplasmic shuttling.
Scholz RP; Regner J; Theil A; Erlmann P; Holeiter G; Jähne R; Schmid S; Hausser A; Olayioye MA
J Cell Sci; 2009 Jan; 122(Pt 1):92-102. PubMed ID: 19066281
[TBL] [Abstract][Full Text] [Related]
11. DLC-1, a GTPase-activating protein for Rho, is associated with cell proliferation, morphology, and migration in human hepatocellular carcinoma.
Kim TY; Lee JW; Kim HP; Jong HS; Kim TY; Jung M; Bang YJ
Biochem Biophys Res Commun; 2007 Mar; 355(1):72-7. PubMed ID: 17292327
[TBL] [Abstract][Full Text] [Related]
12. Differential regulation of the activity of deleted in liver cancer 1 (DLC1) by tensins controls cell migration and transformation.
Cao X; Voss C; Zhao B; Kaneko T; Li SS
Proc Natl Acad Sci U S A; 2012 Jan; 109(5):1455-60. PubMed ID: 22307599
[TBL] [Abstract][Full Text] [Related]
13. Morphological changes and nuclear translocation of DLC1 tumor suppressor protein precede apoptosis in human non-small cell lung carcinoma cells.
Yuan BZ; Jefferson AM; Millecchia L; Popescu NC; Reynolds SH
Exp Cell Res; 2007 Nov; 313(18):3868-80. PubMed ID: 17888903
[TBL] [Abstract][Full Text] [Related]
14. Restoration of DLC1 gene inhibits proliferation and migration of human colon cancer HT29 cells.
Wu PP; Jin YL; Shang YF; Jin Z; Wu P; Huang PL
Ann Clin Lab Sci; 2009; 39(3):263-9. PubMed ID: 19667410
[TBL] [Abstract][Full Text] [Related]
15. The tumor suppressor protein DLC1 is regulated by PKD-mediated GAP domain phosphorylation.
Scholz RP; Gustafsson JO; Hoffmann P; Jaiswal M; Ahmadian MR; Eisler SA; Erlmann P; Schmid S; Hausser A; Olayioye MA
Exp Cell Res; 2011 Feb; 317(4):496-503. PubMed ID: 21087603
[TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor activates the Rho GTPase-activating protein (GAP) Deleted in Liver Cancer 1 via focal adhesion kinase and protein phosphatase 2A.
Ravi A; Kaushik S; Ravichandran A; Pan CQ; Low BC
J Biol Chem; 2015 Feb; 290(7):4149-62. PubMed ID: 25525271
[TBL] [Abstract][Full Text] [Related]
17. Ursodeoxycholic acid-induced inhibition of DLC1 protein degradation leads to suppression of hepatocellular carcinoma cell growth.
Chung GE; Yoon JH; Lee JH; Kim HY; Myung SJ; Yu SJ; Lee SH; Lee SM; Kim YJ; Lee HS
Oncol Rep; 2011 Jun; 25(6):1739-46. PubMed ID: 21455586
[TBL] [Abstract][Full Text] [Related]
18. Deleted in liver cancer 1 (DLC1) negatively regulates Rho/ROCK/MLC pathway in hepatocellular carcinoma.
Wong CC; Wong CM; Ko FC; Chan LK; Ching YP; Yam JW; Ng IO
PLoS One; 2008 Jul; 3(7):e2779. PubMed ID: 18648664
[TBL] [Abstract][Full Text] [Related]
19. FKBP51 regulates cell motility and invasion via RhoA signaling.
Takaoka M; Ito S; Miki Y; Nakanishi A
Cancer Sci; 2017 Mar; 108(3):380-389. PubMed ID: 28032931
[TBL] [Abstract][Full Text] [Related]
20. The RhoA GTPase-activating protein DLC2 modulates RhoA activity and hyperalgesia to noxious thermal and inflammatory stimuli.
Chan FK; Chung SS; Ng IO; Chung SK
Neurosignals; 2012; 20(2):112-26. PubMed ID: 22204965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
